One of the most significant challenges that pharmacist entrepreneurs encounter is obtaining buy-in from their team members, particularly within the dynamic and regulated landscape of the healthcare industry.
The province says a new centre will tackle backlogs by providing a one-stop spot for people to access care, including diagnostic imaging, consultations and post-treatment.
The new drug Litfulo (ritlecitinib) has reached the Canadian market, while baricitinib (Olumiant) is now approved for alopecia areata and in a new higher-strength tablet.
'We need to move expeditiously' to lock down a comprehensive care funding model, said Alberta Medical Association president Dr. Paul Parks. 'The urgency is still very real.'
